Financial Instruments | Note 2. Financial Instruments Investments The following tables present information about our financial assets measured at fair value on a recurring basis as of March 31, 2017 and December 31, 2016 based on the three-tier fair value hierarchy (in thousands): Fair Value Measurement at Level 1 Level 2 Total Description Corporate bonds $ — $ 131,527 $ 131,527 U.S. treasury securities 30,564 30,564 Asset-backed securities — 30,399 30,399 Agency securities 8,485 8,485 Commercial paper — 5,785 5,785 Money market funds 3,825 — 3,825 Total $ 3,825 $ 206,760 $ 210,585 Included in cash and cash equivalents $ 3,825 Included in marketable securities $ 206,760 Fair Value Measurement at Level 1 Level 2 Total Description Corporate bonds $ — $ 124,930 $ 124,930 Asset-backed securities 32,567 32,567 U.S. treasury securities 30,585 30,585 Commercial paper 9,787 9,787 Agency securities 8,489 8,489 Money market funds 3,545 $ — $ 3,545 Total $ 3,545 $ 206,358 $ 209,903 Included in cash and cash equivalents $ 3,545 Included in marketable securities $ 206,358 As of March 31, 2017 and December 31, 2016 , there were no securities within Level 3 of the fair value hierarchy. There were no transfers between fair value measurement levels during the three months ended March 31, 2017 . Gross unrealized gains and losses for cash equivalents and marketable securities as of March 31, 2017 and December 31, 2016 were no t material. As of March 31, 2017 and December 31, 2016 , there were no securities that were in an unrealized loss position for more than 12 months . The following table classifies our marketable securities by contractual maturity as of March 31, 2017 and December 31, 2016 (in thousands): March 31, December 31, Due in one year or less $ 138,440 $ 131,190 Due after one year 68,320 75,168 Total $ 206,760 $ 206,358 For certain other financial instruments, including accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their fair value due to the relatively short maturity of these balances. Derivative Instruments and Hedging Our foreign currency exposures typically arise from expenditures associated with foreign operations and sales in foreign currencies for subscriptions to our products. In September 2015, we implemented a hedging program to mitigate the effect of foreign currency fluctuations on our future cash flows and earnings. We enter into foreign currency forward contracts with certain financial institutions and designate those contracts as cash flow hedges. Our foreign currency forward contracts generally have maturities of 15 months or less. As of March 31, 2017 , the balance of accumulated other comprehensive loss included an unrealized loss of $1.5 million related to the effective portion of changes in the fair value of foreign currency forward contracts designated as cash flow hedges. We expect to reclassify $1.5 million from accumulated other comprehensive loss into earnings over the next 12 months associated with our cash flow hedges. The following tables present information about our derivative instruments on our consolidated balance sheets as of March 31, 2017 and December 31, 2016 (in thousands): March 31, 2017 Asset Derivatives Liability Derivatives Derivative Instrument Balance Sheet Location Fair Value (Level 2) Balance Sheet Location Fair Value (Level 2) Foreign currency forward contracts Other current assets $ 729 Accrued liabilities $ 2,740 Total $ 729 $ 2,740 December 31, 2016 Asset Derivatives Liability Derivatives Derivative Instrument Balance Sheet Location Fair Value (Level 2) Balance Sheet Location Fair Value (Level 2) Foreign currency forward contracts Other current assets $ 868 Accrued liabilities $ 4,280 Total $ 868 $ 4,280 Our foreign currency forward contracts had a total notional value of $81.3 million and $79.6 million as of March 31, 2017 and December 31, 2016 , respectively. We have a master netting arrangement with each of our counterparties, which permits net settlement of multiple, separate derivative contracts with a single payment. We may also be required to exchange cash collateral with certain of our counterparties on a regular basis. ASC 815 permits companies to present the fair value of derivative instruments on a net basis according to master netting arrangements. We have elected to present our derivative instruments on a gross basis in our consolidated financial statements. As of March 31, 2017 and December 31, 2016 , our balances of cash collateral posted with counterparties were none and $1.1 million , respectively. The following table presents information about our derivative instruments on the statement of operations for the three months ended March 31, 2017 and 2016 (in thousands): Three Months Ended March 31, 2017 Three Months Ended March 31, 2016 Hedging Instrument Location of Loss Reclassified into Earnings Gain Recognized in AOCI Loss Reclassified from AOCI into Earnings Gain Recognized in AOCI Loss Reclassified from AOCI into Earnings Foreign currency forward contracts Revenue, cost of revenue, operating expenses $ 993 $ (533 ) $ 2,348 $ (262 ) Total $ 993 $ (533 ) $ 2,348 $ (262 ) All derivatives have been designated as hedging instruments. Amounts recognized in earnings related to excluded time value and hedge ineffectiveness for the three months ended March 31, 2017 and 2016 were not material . |